<?xml version="1.0" encoding="UTF-8"?>
<p id="Par78">This large prospective, multicentre, randomised, double-blinded, placebo-controlled trial aims to test the hypothesis that lock solution with taurolidine-citrate-heparin is more effective than placebo for preventing CVC catheter infection in high-risk neutropenic haematological patients and, consequently, CRBSI.</p>
